AB SCIENCE |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.9 EUR | -1.86% |
|
-4.90% | -46.55% |
| 04-04 | AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada | MT |
| 04-03 | AB Science: reconsideration possible for masitinib in ALS | CF |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 2.240 | 2.605 | 3.130 |
| Spread/Res. | -15.18% | -27.06% | -39.30% |
| Spread/Supp. | +0.85% | +0.85% | +9.83% |
| Support | 1.884 | 1.884 | 1.730 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- AB Stock
- Charts AB Science
